News | November 02, 2023
Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022
Most of the new growth Capex investments are happening on the Specialty Chemicals and Nutrition side
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
The commissioned facility has a capacity of 7,000 TPA to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate, and Ter-Butyl Acetoacetate)
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The event will be attended by 35,000+ industry professionals
Subscribe To Our Newsletter & Stay Updated
